INCY Competitors
Incyte Corporation
$111.57
+$2.95(+2.72%)
58
Overall
80
Value
27
Tech
68
Quality
Market Cap
$22.61B
Volume
1.87M
52W Range
$82.82 - $132.60
Target Price
$130.36
INCY competitors: AMGN, LGND, LLY, PFE, GERN. Incyte Corporation is compared with its Healthcare peers on market cap, P/E ratio, dividend yield and performance.
INCY Competitors Compared
| Company | Price | Market cap | EPS est. (current yr) | Dividend yield | MarketXLS Rank |
|---|---|---|---|---|---|
| AMGN Amgen Inc. | $426.11 | $230.37B | $22.94 | 2.33% | 65 |
| LGND Ligand Pharmaceuticals Incorporated | $294.99 | $5.88B | $5.25 | - | 69 |
| LLY Eli Lilly and Company | $1211.57 | $1.10T | $36.19 | 0.55% | 60 |
| PFE Pfizer Inc. | $29.21 | $166.49B | $2.96 | 5.89% | 70 |
| GERN Geron Corporation | $1.19 | $764.54M | $-0.04 | - | 40 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | INCY | $111.57 | +2.7% | 1.87M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |